Savage, T. M., Fortson, K. T., de los Santos-Alexis, K., Oliveras-Alsina, A., Rouanne, M., Rae, S. S., Gamarra, J. R., Shayya, H., Kornberg, A., Cavero, R., Li, F., Han, A., Haeusler, R. A., Adam, J., Schwabe, R. F., & Arpaia, N. (2024). Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis. Immunity, 57(2), 303-318.e6. https://doi.org/10.1016/j.immuni.2024.01.009

Oh, A.-R., Jeong, Y., Yu, J., Minh Tam, D. T., Kang, J. K., Jung, Y. H., Im, S.-S., Lee, S. B., Ryu, D., Pajvani, U. B., & Kim, K. (2023). Hepatocyte Kctd17 Inhibition Ameliorates Glucose Intolerance and Hepatic Steatosis Caused by Obesity-induced Chrebp Stabilization. Gastroenterology, 164(3), 439–453. https://doi.org/10.1053/j.gastro.2022.11.019

Shah, A., Prasad, M., Mark, V., Holst, J. J., & Laferrère, B. (2022). Glucagon‐like peptide‐1 effect on β‐cell function varies according to diabetes remission status after Roux‐en‐Y gastric bypass. Diabetes, Obesity and Metabolism, 24(11), 2081–2089. Portico. https://doi.org/10.1111/dom.14793

Wang, Y., Spolitu, S., Zadroga, J. A., Sarecha, A. K., & Ozcan, L. (2022). Hepatocyte Rap1a contributes to obesity- and statin-associated hyperglycemia. Cell Reports, 40(8), 111259. https://doi.org/10.1016/j.celrep.2022.111259

Bartolomé, A., Suda, N., Yu, J., Zhu, C., Son, J., Ding, H., Califano, A., Accili, D., & Pajvani, U. B. (2022). Notch-mediated Ephrin signaling disrupts islet architecture and β cell function. JCI Insight, 7(6). https://doi.org/10.1172/jci.insight.157694